Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krystyna Olczyk

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Postepy Higieny I Medycyny Doswiadczalnej|January 24, 2004
[Methods of collagenous tissue fixation in the preparation of bioprostheses]Paweł Olczyk, Kornelia Kuźnik-Trocha, Krystyna Olczyk, et al.
Clinical Biochemistry|June 24, 2014
Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent populationKatarzyna Komosinska-Vassev, Dorota Blat, Paweł Olczyk, et al.
Journal of Clinical Medicine|September 9, 2022
GAAGs, COMP, and YKL-40 as Potential Markers of Cartilage Turnover in Blood of Children with Juvenile Idiopathic Arthritis Treated with Etanercept-Relationship with ADAMTS4, ADAMTS5, and PDGF-BBKlaudia Dąbkowska, Magdalena Wojdas, Kornelia Kuźnik-Trocha, et al.
Journal of Zhejiang University. Science. B|November 6, 2012
Propolis modulates vitronectin, laminin, and heparan sulfate/heparin expression during experimental burn healingPaweł Olczyk, Katarzyna Komosińska-Vassev, Katarzyna Winsz-Szczotka, et al.
Journal of Clinical Medicine|May 7, 2020
Significant Remodeling Affects the Circulating Glycosaminoglycan Profile in Adult Patients with both Severe and Mild Forms of Acute PancreatitisEwa M Koźma, Kornelia Kuźnik-Trocha, Katarzyna Winsz-Szczotka, et al.
Biomedicines|August 26, 2022
Plasma Glycosaminoglycans in Children with Juvenile Idiopathic Arthritis Being Treated with Etanercept as Potential Biomarkers of Joint DysfunctionMagdalena Wojdas, Klaudia Dąbkowska, Kornelia Kuźnik-Trocha, et al.
Biomolecules|January 8, 2025
Serum CS/DS, IGF-1, and IGFBP-3 as Biomarkers of Cartilage Remodeling in Juvenile Idiopathic Arthritis: Diagnostic and Therapeutic ImplicationsKatarzyna Winsz-Szczotka, Kornelia Kuźnik-Trocha, Ewa M Koźma, et al.
Journal of Clinical Medicine|February 26, 2025
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with MetforminAnna Szeremeta, Agnieszka Jura-Półtorak, Alicja Grim, et al.
Biomed Research International|May 9, 2020
Plasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-BetaKornelia Kuźnik-Trocha, Katarzyna Winsz-Szczotka, Katarzyna Komosińska-Vassev, et al.
Biochemical and Biophysical Research Communications|February 17, 2015
Plasma and urinary glycosaminoglycans in the course of juvenile idiopathic arthritisKatarzyna Winsz-Szczotka, Kornelia Kuźnik-Trocha, Katarzyna Komosińska-Vassev, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Postepy Higieny I Medycyny Doswiadczalnej|January 24, 2004
[Methods of collagenous tissue fixation in the preparation of bioprostheses]Paweł Olczyk, Kornelia Kuźnik-Trocha, Krystyna Olczyk, et al.
Clinical Biochemistry|June 24, 2014
Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent populationKatarzyna Komosinska-Vassev, Dorota Blat, Paweł Olczyk, et al.
Journal of Clinical Medicine|September 9, 2022
GAAGs, COMP, and YKL-40 as Potential Markers of Cartilage Turnover in Blood of Children with Juvenile Idiopathic Arthritis Treated with Etanercept-Relationship with ADAMTS4, ADAMTS5, and PDGF-BBKlaudia Dąbkowska, Magdalena Wojdas, Kornelia Kuźnik-Trocha, et al.
Journal of Zhejiang University. Science. B|November 6, 2012
Propolis modulates vitronectin, laminin, and heparan sulfate/heparin expression during experimental burn healingPaweł Olczyk, Katarzyna Komosińska-Vassev, Katarzyna Winsz-Szczotka, et al.
Journal of Clinical Medicine|May 7, 2020
Significant Remodeling Affects the Circulating Glycosaminoglycan Profile in Adult Patients with both Severe and Mild Forms of Acute PancreatitisEwa M Koźma, Kornelia Kuźnik-Trocha, Katarzyna Winsz-Szczotka, et al.
Biomedicines|August 26, 2022
Plasma Glycosaminoglycans in Children with Juvenile Idiopathic Arthritis Being Treated with Etanercept as Potential Biomarkers of Joint DysfunctionMagdalena Wojdas, Klaudia Dąbkowska, Kornelia Kuźnik-Trocha, et al.
Biomolecules|January 8, 2025
Serum CS/DS, IGF-1, and IGFBP-3 as Biomarkers of Cartilage Remodeling in Juvenile Idiopathic Arthritis: Diagnostic and Therapeutic ImplicationsKatarzyna Winsz-Szczotka, Kornelia Kuźnik-Trocha, Ewa M Koźma, et al.
Journal of Clinical Medicine|February 26, 2025
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with MetforminAnna Szeremeta, Agnieszka Jura-Półtorak, Alicja Grim, et al.
Biomed Research International|May 9, 2020
Plasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-BetaKornelia Kuźnik-Trocha, Katarzyna Winsz-Szczotka, Katarzyna Komosińska-Vassev, et al.
Biochemical and Biophysical Research Communications|February 17, 2015
Plasma and urinary glycosaminoglycans in the course of juvenile idiopathic arthritisKatarzyna Winsz-Szczotka, Kornelia Kuźnik-Trocha, Katarzyna Komosińska-Vassev, et al.
Pageof 8